Nonspecific chemical immunosuppression.
D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D000925:Anticoagulants / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D003208:Concanavalin A / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005231:Fatty Acids, Unsaturated / Q000494:pharmacology; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007093:Imidazoles / Q000494:pharmacology; D007165:Immunosuppression Therapy / Q000379:methods*; D010456:Peptides, Cyclic / Q000494:pharmacology; D045167:Progesterone Congeners / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology; D013256:Steroids / Q000627:therapeutic use; D013994:Tilorone / Q000494:pharmacology; D014019:Tissue Donors
D058892:Adenosine Deaminase Inhibitors; D000925:Anticoagulants; D005231:Fatty Acids, Unsaturated; D007093:Imidazoles; D010456:Peptides, Cyclic; D045167:Progesterone Congeners; D011453:Prostaglandins; D013256:Steroids; D003208:Concanavalin A; D001379:Azathioprine; D013994:Tilorone